Compound Detail
CHEMBL38380
FASUDIL 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL38380 |
| Name | FASUDIL |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | NGOGFTYYXHNFQH-UHFFFAOYSA-N |
50
Targets
130
Activities
3
Assay Types
17
PK Parameters
20
Publications
7
Known Names
5
Indications
1
Mechanisms
Molecular Properties
291.4
MW (Da)
1.22
ALogP
4
HBA
1
HBD
62.3
PSA (Ų)
0.90
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Rho-associated protein kinase inhibitor | INHIBITOR | Rho-associated protein kinase | ✓ | ✓ |
Indications
Cardiovascular Diseases Amyotrophic Lateral Sclerosis Dementia Retinal Vein Occlusion Retinopathy of Prematurity
ATC Classification
C04AX32
fasudil
Level 1: CARDIOVASCULAR SYSTEM
Level 2: PERIPHERAL VASODILATORS
Activity Summary
IC50 54 meas. best 6.8
Ki 53 meas. best 7.5
Kd 23 meas. best 7.35
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Rho-associated protein kinase 1 CHEMBL3231 | Ki | 7.5 | 6.76 | 31.6 | 7 |
| Rho-associated protein kinase 2 CHEMBL2973 | Kd | 7.35 | 6.83 | 45.0 | 3 |
| Rho-associated protein kinase 1 CHEMBL3231 | Kd | 7.3 | 6.67 | 50.0 | 2 |
| Rho-associated protein kinase 2 CHEMBL2973 | Ki | 7.3 | 7.0267 | 50.1 | 3 |
| cAMP-dependent protein kinase catalytic subunit PRKX CHEMBL5818 | Ki | 7.3 | 7.3 | 50.1 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha CHEMBL4101 | Ki | 7.1 | 7.1 | 79.4 | 2 |
| Serine/threonine-protein kinase N3 CHEMBL3627581 | Kd | 7.0 | 7.0 | 99.0 | 1 |
| Dual specificity protein kinase CLK1 CHEMBL4224 | Kd | 6.82 | 6.82 | 152.0 | 1 |
| Rho-associated protein kinase 2 CHEMBL2973 | IC50 | 6.8 | 6.2757 | 158.0 | 14 |
| Rho-associated protein kinase CHEMBL2111459 | IC50 | 6.75 | 6.75 | 180.0 | 1 |
| No relevant target CHEMBL2362975 | IC50 | 6.75 | 6.75 | 180.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.74 | 5.5118 | 182.0 | 11 |
| Unchecked CHEMBL612545 | Kd | 6.61 | 6.495 | 247.0 | 2 |
| Rho-associated protein kinase 1 CHEMBL3231 | IC50 | 6.58 | 6.1675 | 260.0 | 8 |
| Dual specificity protein kinase CLK4 CHEMBL4203 | Ki | 6.5 | 6.5 | 316.2 | 2 |
| Rho-associated protein kinase CHEMBL2111459 | Ki | 6.48 | 6.48 | 330.0 | 1 |
| cAMP-dependent protein kinase (PKA) CHEMBL2094138 | Ki | 6.34 | 6.34 | 460.0 | 1 |
| Protein kinase C theta type CHEMBL3920 | Ki | 6.2 | 6.2 | 631.0 | 2 |
| Uterus CHEMBL4296544 | IC50 | 6.11 | 6.11 | 781.0 | 1 |
| Serine/threonine-protein kinase N2 CHEMBL3032 | IC50 | 6.11 | 5.8733 | 780.0 | 3 |
| Serine/threonine-protein kinase N1 CHEMBL3384 | Kd | 6.08 | 6.08 | 841.0 | 1 |
| Serine/threonine-protein kinase D3 CHEMBL2595 | Ki | 6.0 | 6.0 | 1000.0 | 2 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | Ki | 6.0 | 6.0 | 1000.0 | 2 |
| Ribosomal protein S6 kinase beta-1 CHEMBL4501 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
| Death-associated protein kinase 3 CHEMBL2468 | Ki | 5.9 | 5.9 | 1258.9 | 2 |
| Cyclin-dependent kinase 8 CHEMBL5719 | Ki | 5.9 | 5.9 | 1258.9 | 2 |
| Serine/threonine-protein kinase D2 CHEMBL4900 | Ki | 5.9 | 5.9 | 1258.9 | 2 |
| HASMC CHEMBL614150 | IC50 | 5.89 | 5.89 | 1300.0 | 1 |
| Serine/threonine-protein kinase N1 CHEMBL3384 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Maternal embryonic leucine zipper kinase CHEMBL4578 | Kd | 5.72 | 5.72 | 1922.0 | 1 |
| Rho-associated protein kinase 2 CHEMBL5490 | IC50 | 5.72 | 5.72 | 1900.0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | Ki | 5.7 | 5.7 | 1995.3 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] CHEMBL3959 | Kd | 5.61 | 5.61 | 2451.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Ki | 5.6 | 5.6 | 2511.9 | 2 |
| Protein kinase C delta type CHEMBL2996 | Ki | 5.6 | 5.6 | 2511.9 | 2 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Ki | 5.6 | 5.6 | 2511.9 | 2 |
| Aurora kinase B CHEMBL2185 | Ki | 5.6 | 5.6 | 2511.9 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 4 CHEMBL6166 | Ki | 5.6 | 5.6 | 2511.9 | 2 |
| Serine/threonine-protein kinase N2 CHEMBL3032 | Kd | 5.58 | 5.58 | 2599.0 | 1 |
| Protein kinase C epsilon type CHEMBL3582 | IC50 | 5.52 | 5.52 | 3000.0 | 2 |
| RAC-alpha serine/threonine-protein kinase CHEMBL4282 | Ki | 5.5 | 5.5 | 3162.3 | 2 |
| Cyclin-dependent kinase 12 CHEMBL3559692 | Kd | 5.46 | 5.46 | 3480.0 | 1 |
| Myosin light chain kinase, smooth muscle CHEMBL2428 | IC50 | 5.44 | 5.055 | 3600.0 | 2 |
| Protein kinase C gamma type CHEMBL2938 | Ki | 5.4 | 5.4 | 3981.1 | 2 |
| Serine/threonine-protein kinase LATS1 CHEMBL6167 | Kd | 5.38 | 5.38 | 4170.0 | 1 |
| Cyclin-dependent kinase 9 CHEMBL3116 | Kd | 5.37 | 5.37 | 4251.0 | 1 |
| Cyclin-dependent kinase 13 CHEMBL1795192 | Kd | 5.34 | 5.34 | 4518.0 | 1 |
| cAMP-dependent protein kinase (PKA) CHEMBL2094138 | IC50 | 5.34 | 5.34 | 4580.0 | 2 |
| Protein kinase C delta type CHEMBL2996 | Kd | 5.32 | 5.32 | 4789.0 | 1 |
| Ribosomal protein S6 kinase alpha-5 CHEMBL4237 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | - | - | Rattus norvegicus |
| CL | - | - | Rattus norvegicus |
| CL | 318.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 10.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 150.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 198.1 | mL.min-1.kg-1 | Mus musculus |
| CL | 35.7 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 73.2 | mL.min-1.kg-1 | Homo sapiens |
| F | - | % | Rattus norvegicus |
| F | 3.6 | % | Mus musculus |
| Fu | 0.51 | - | Homo sapiens |
| t1/2 | - | - | Rattus norvegicus |
| T1/2 | 1.217 | hr | Homo sapiens |
| t1/2 | - | - | Rattus norvegicus |
| T1/2 | 0.02 | hr | Mus musculus |
| T1/2 | 0.3 | hr | Mus musculus |
| T1/2 | 0.26 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10998351 | 10.1042/0264-6021:3510095 | Unchecked | 9 |
| 33569941 | 10.1021/acs.jmedchem.0c01901 | Rattus norvegicus | 6 |
| 29909615 | 10.1021/acs.jmedchem.8b00105 | cAMP-dependent protein kinase catalytic subunit alpha | 6 |
| 20462760 | 10.1016/j.bmcl.2010.04.070 | Rattus norvegicus | 5 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin receptor | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Lck | 4 |
| 23398362 | 10.1042/bj20121418 | cGMP-dependent protein kinase 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Protein kinase C beta type | 4 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 5/CDK5 activator 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase mTOR | 4 |
| 29269216 | 10.1016/j.bmcl.2017.12.017 | Uterus | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase HCK | 4 |
| 19740074 | 10.1042/bj20091035 | Leucine-rich repeat serine/threonine-protein kinase 2 | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin-like growth factor 1 receptor | 4 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| 21145740 | 10.1016/j.bmcl.2010.11.060 | Mus musculus | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22521647 | 10.1016/j.bmcl.2012.03.101 | Unchecked | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
Data from ChEMBL 36 via Core Engine